NLRP3-IN-19

Modify Date: 2024-07-08 17:01:35

NLRP3-IN-19 structure	Common Name	NLRP3-IN-19
	CAS Number	2238819-65-1	Molecular Weight	402.47
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₁₉H₂₂N₄O₄S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of NLRP3-IN-19

JT001 (NLRP3-IN-19) is a potent, specific and orally active inhibitor of NLRP3. JT001 can inhibit NLRP3 inflammasome assembly, resulting in the inhibition of cytokine release and the prevention of pyroptosis. JT001 can be used for the research of nonalcoholic steatohepatitis and liver fibrosis[1].

Name	NLRP3-IN-19

Description	JT001 (NLRP3-IN-19) is a potent, specific and orally active inhibitor of NLRP3. JT001 can inhibit NLRP3 inflammasome assembly, resulting in the inhibition of cytokine release and the prevention of pyroptosis. JT001 can be used for the research of nonalcoholic steatohepatitis and liver fibrosis[1].
Related Catalog	Signaling Pathways >> Immunology/Inflammation >> NOD-like Receptor (NLR) Research Areas >> Inflammation/Immunology
Target	NLRP3
References	[1]. Povero D, et, al. Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis. J Pharmacol Exp Ther. 2023 Aug;386(2):242-258.

Molecular Formula	C₁₉H₂₂N₄O₄S
Molecular Weight	402.47

NLRP3-IN-19

Use of NLRP3-IN-19

Names

NLRP3-IN-19 Biological Activity

Chemical & Physical Properties